Translate page

Vasile Musteata, MD, PhD, MPHIMG Musteata

Associate Professor and vice-head for education

Department of Oncology, Hematology and Radiotherapy
“N. Testemitanu” State University of Medicine and Pharmacy

Chisinau, Moldova

Current professional position:

  • Associate Professor and vice-head for education at the Department of Oncology, Hematology and Radiotherapy, “N. Testemitanu” State University of Medicine and Pharmacy
  • Attending physician, division of Hematology, Institute of Oncology
  • Clinical expert at the Agency of Medicine and Medical Devices
  • GIPAP manager for Moldova

Fields of scientific activities:

  • Diagnosis and treatment of malignant lymphomas and chronic leukemias
  • Publications in peer-reviewed periodicals: 125 articles and abstracts (including 6 National Clinical Protocols), one invention

Postgraduate training and fellowships:

1. Postgraduate Medical Education Program in the speciality of Hematology, dept. of Hematology and Oncology, “N. Testemitanu” State University of Medicine and Pharmacy, Institute of Oncology; Chisinau, 1995 – 1997; MD degree

2. Internship on Hematology, Department of Hematology and Oncology, Krankenhaus Moabit; Berlin, Germany, 1 November  – 30 December  1998

3. Salzburg – Cornell Seminars on Oncology/ Hematology under the auspices of Memorial Sloan-Kettering Cancer Center of New-York; Austria, 14 – 19 March 1999

4. International Scientific Conference Actual Problems of Clinical Hematology and Transfusion Medicine under the auspices of P.L. Shupyk Kyiv Medical Academy for Postgraduate Education; Ukraine, 1 – 3 June 1999

5. The AAF-OSI Medical Internship Program on Oncology and Hematology, Division of Hematology and Oncology, Innsbruck University Clinic; Austria, 30 September – 29 October  2000

6. Postgraduate Course on Hematology and Transfusion Medicine, dept. of Hematology and Oncology, “N. Testemitanu” State University of Medicine and Pharmacy, Institute of Oncology; Chisinau, 1997 – 2000; PhD degree

7. XXVII-ème Semaine Mèdicale Balkanique, L’Union Mèdicale Balkanique; Chisinau, Republic of Moldova, 19 – 21 June 2002

8. 27th European Society for Medical Oncology (ESMO) Congress; Nice, France, 18 – 22 October 2002

9. ESMO Summer Educational Conference; Edinburgh, Scotland, UK, 19 – 22 June 2003

10. Medical Internship Program on Internal Medicine / Hematology, Division of Internal Medicine and Hematology, King Abdullah University Hospital, Jordan University of Science and Technology; Irbid, Hashemite Kingdom of Jordan, 15 July  – 8 August  2003

11. ESMO Postgraduate Course Principles and Practices in Medical Oncology, Maria Sklodowska-Curie Memorial Cancer Center; Warsaw, Poland, 4 – 6 September 2003

12. 29th ESMO Congress; Vienna, Austria, 29 October – 2 November 2004

13. ESMO Scientific and Educational Conference; Budapest, Hungary, 2 – 5 June 2005

14. Regional meeting of national managers – SEE Blood safety project under the auspices of WHO; Ljubljana, Slovenia, 17 – 18 June 2005

15. Salzburg – Cornell Seminars on Oncology under the auspices of Memorial Sloan-Kettering Cancer Center of New-York; Austria, 10 – 16 September 2006

16. 31th ESMO Congress; Istanbul, Turkey, 29 September – 3 October 2006

17. TEMPUS-TACIS „PROBMEDFORM” Project and CBCR-Seminars, L’Universita Cattolica del Sacro Cuore di Milano, Rome, Italy, 20 – 26 November 2006

18. Ukrainian School of Hematologists “Updated problems of treatment of hematological and viral diseases”; Kyiv, 19 – 20  June  2008

19. 33th ESMO Congress; Stockholm, Sweden, 12 – 16 September 2008

20. School of  Public Health, N. Testemitanu” State University of Medicine and Pharmacy “; Chisinau, 2009 – 2011; MPH degree

21. Seminars “Perfections in Management of Public Health” under the auspices of Ecole de Santé Publique – Groupe Hospitalier Saint Augustin; France, 9 – 13 May 2011

22. Salzburg – Cornell Seminars on Oncology A: Hematologic Malignancies under the auspices of Memorial Sloan-Kettering Cancer Center of New-York; Austria, 22 – 28 April 2012

23. ERSAP Preceptorship Program in hematologic malignancies, Department of Leukemia, The University of Texas, MD Anderson Cancer Center; Houston, Texas, USA, 1 – 31 August 2012

24. 11th Annual Symposium of the European LeukemiaNet / 15th Annual Symposium of the German Competence Network “Acute and chronic Leukemias”; Mannheim, Germany, 4 – 5 February, 2014

john goldmanRemembering John Goldman

It is with great sorrow that the iCMLf has learned of the death of Professor John Goldman, after a short illness.

With a worldwide reputation in the study of the biology and treatment of CML, John was a true leader, teacher and inspiration to so many.

Read more about John Goldman here and access our remembrance page for John where you can share your thoughts and memories.

Presented by the International CML Foundation
in partnership with The Max Foundation




iCMLf Forum for Physicians
from Emerging Economic Regions

‘Overcoming challenges treating CML’

Featuring practical innovations and discussion with CML experts
during the annual American Society of Hematology meeting
Friday 6 December 2013
4.00 pm - 6.00 pm
Hilton Garden Inn New Orleans Convention Center, New Orleans, USA
>> To reserve your place, please register here <<

DSC09076-100iCMLf Forum 2012: Webstreams of presentations now available

Webstreams of all presentations of the International CML Foundation Forum, held in partnership with The Max Foundation during the meeting of the American Society of Hematology (ASH) in Atlanta on 7 December 2012, are now available.

Disclaimer of the ICMLF Discussion Forum Rules

Eligibility for Participation

This discussion forum is for registered members of the iCMLf website only. Participants must be 18 years of age or older. The account (username, password) must not be given to any third party.



Health-related Information

Please be aware that all contributions should not be treated as or seen to constitute professional opinion or medical advice. You agree to accept all information detailed in the forum at your own risk and that you may not hold any contributor, moderator or site owner liable or responsible for any information or advice that appears on this page.


More specifically, the CML case discussion forum has been established to facilitate a dialogue amongst clinicians about difficult management and diagnostic issues related to the care of CML patients. Opinions submitted are meant to be of a general nature and should not be regarded as specific medical advice for the patient under discussion or for any other patient. Patients who feel that any of the opinions offered on this forum may be relevant in their case should discuss the matter with their treating clinician.


Privacy Policy

In order to use these forums, users are required to provide their organisation's name, username, password and e-mail address.


Neither the administrators of these forums, or the Moderators participating, are responsible for the privacy practices of any user. Remember that all information that is disclosed in these areas becomes public information and you should exercise caution when deciding to share any of your personal information. Any user who finds material posted by another user objectionable is encouraged to contact us via e-mail.


Cookies must be turned on in your browser to participate as a user in these forums. Cookies are used here to hold your username and password and viewing options, allowing you to login.


Links to other Web Sites

This forum may contain links to other web sites and files. We have no control over the content and can not ensure it will not be offensive or objectionable. We will, however, remove links to material that we feel is inappropriate as we become aware of them.



Each user is individually responsible for any information or file supplied by this user. You also agree that you will not post any copyrighted material that is not owned by yourself or the owners of these forums. In your use of these forums, you agree that you will not post any information which is vulgar, harassing, hateful, threatening, invading of others privacy, sexually oriented, or violates any laws.

The suitability of topics for discussion on and contributions to the Page shall be at the discretion of the site owners and moderators. The moderators are authorized to remove or modify any data submitted to these forums for any reason

they feel it constitutes a violation of our policies, whether stated, implied or not. The site moderators also reserve the right to block anyone from accessing the forum when violating the forum's rules.

If you have any questions about the rules, privacy policy or use of these forums, you can contact the forum administrator at:

EMail notifications


When you are registered on the iCMLf website, you are automatically subscribed to the "Difficult CML cases Forum". Subscription means that you receive an email notification when someone leaves a message in the forum and the moderator approves this message. This way, you will never miss a Forum message as you do not need to return to the forum regularly to check if there are new cases or replies being posted.


If you want to unsubscribe from the Forum messages, please go to the "iCMLf Difficult cases in CML Forum" and then click on the unsubscribebutton. After doing so, you will no longer receive email notifications from this forum.


You can turn on the e-mail notification at any time by clicking on the subscribebutton in the Difficult Cases in CML Forum.


See also the iCMLf Discussion Forum Rules, which describes the privacy policy and the rules for submissions of forum messages.